Can Allogene Therapeutics Inc (ALLO) stock recover despite sales dropping?
In yesterday’s Wall Street session, Allogene Therapeutics Inc (NASDAQ:ALLO) shares traded at $4.66, up 3.67% from the previous session. ALLO stock price is now 12.48% away from the 50-day moving average and 18.83% away from the 200-day moving average. The market capitalization of the company currently stands at $787.96M. , while ‘Citigroup’ rates the stock […]
Does Allogene Therapeutics Inc (NASDAQ:ALLO) warrant a purchase right now? What to Consider Before Making a Decision
Allogene Therapeutics Inc (NASDAQ:ALLO) shares traded 3.31% higher at $2.81 on Wall Street last session. In accordance with the data, 16 analysts cover Allogene Therapeutics Inc (NASDAQ:ALLO). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $35.00 and a low of $4.50, […]
Allogene Therapeutics Inc. (NASDAQ:ALLO): A Fundamentally Weighted Stock for Long-Term Investors
The stock of Allogene Therapeutics Inc. (NASDAQ:ALLO) last traded at $4.73, down -6.52% from the previous session. Data from the available sources indicates that Allogene Therapeutics Inc. (NASDAQ:ALLO) is covered by 19 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
Allogene Therapeutics Inc. (NASDAQ:ALLO): A Fundamentally Weighted Stock for Long-Term Investors
The stock of Allogene Therapeutics Inc. (NASDAQ:ALLO) last traded at $4.58, down -1.08% from the previous session. Data from the available sources indicates that Allogene Therapeutics Inc. (NASDAQ:ALLO) is covered by 19 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
